1. With new funding, Atomic AI envisions RNA as the next frontier in drug discovery  TechCrunch
  2. Atomic AI Launches with $35 Million Series A Financing to Advance AI-driven RNA Structure Platform for Treating Undruggable Diseases  Business Wire
  3. Bay Area biotech uses AI to unlock RNA structures — and find new therapies in the process  STAT
  4. View Full coverage on Google News
With $35M in new funding, Atomic AI aims to do for RNA what AlphaFold did for proteins, and find entirely new treatments in the process.With $35M in new funding, Atomic AI aims to do for RNA what AlphaFold did for proteins, and find entirely new treatments in the process.

With new funding, Atomic AI envisions RNA as the next frontier in drug discovery • TechCrunch

With $35M in new funding, Atomic AI aims to do for RNA what AlphaFold did for proteins, and find entirely new treatments in the process.With $35M in new funding, Atomic AI aims to do for RNA what AlphaFold did for proteins, and find entirely new treatments in the process.

With new funding, Atomic AI envisions RNA as the next frontier in drug discovery • TechCrunch

At the heart of the startup’s approach is a basic insight: RNA molecules are not the straight lines they’re depicted as in textbooks.A new Bay Area biotech is harnessing artificial intelligence to better understand and predict RNA structures in hopes of developing new therapeutics.

Bay Area biotech uses AI to unlock RNA structures - STAT